|
 |
 |
|
 |
 |
|
NOVEMBER 16 - 17, 2007
12th Annual Perspectives in Thoracic Oncology
New York, New York
Westin New York Times Square
Chair:
Corey J. Langer, MD, FACP
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Click
here to register for this program |
 |
|
I N V I T A T I O N |
 |
|
|
Dear Colleague,
It is my pleasure to invite you to join us at the 12th Annual Perspectives in Thoracic Oncology, November 16-17, 2007 at the Westin New York Times Square in New York, New York.
Amongst thoracic cancer clinicians and researchers, there is a growing need to review and synthesize the latest information on the complex biology and treatment of lung cancer. The field is constantly evolving; there are many controversial issues in disease biology, management, and research that pose a continual challenge for clinical practitioners.
Over the past twelve years, this meeting has become the premier source for state-of-the-art presentations on the diagnosis and treatment of thoracic oncology, allowing attendees to update their knowledge in the field, confirm or alter their current practices and glean valuable take-home messages regarding new and exciting therapeutic approaches.
With a vibrant mix of oncologists, surgeons, and pulmonologists, this conference provides a great forum to interact with your colleagues and to learn from internationally renowned faculty.
I hope you will be able to join us for this exciting two day meeting; we look forward to welcoming you to New York as the fall brings its beauty to this international city.
Sincerely,
Corey J. Langer, MD, FACP
|
|
|
|
F A C U L T Y |
|
|
|
Walter
J. Curran, Jr, MD
Thomas
Jefferson University
Philadelphia,
Pennsylvania
Carolyn
M. Dresler, MD, MPA
University
of Arkansas for Medical Sciences
Little
Rock, Arkansas
Damian
E. Dupuy, MD
Rhode
Island Hospital
Brown
Medical School
Providence,
Rhode Island
Vera
Hirsh, MD
McGill
University
Montreal,
Québec, Canada
Karen
L. Kelly, MD
University
of Colorado
Denver,
Colorado
|
Hedy
L. Kindler, MD
University
of Chicago
Chicago,
Illinois
John
C. Kucharczuk, MD
University
of Pennsylvania School of Medicine
Philadelphia,
Pennsylvania
Corey
J. Langer, MD, FACP
Fox
Chase Cancer Center
Philadelphia,
Pennsylvania
Scott
M. Lippman, MD
M.
D. Anderson Cancer Center
Houston,
Texas
|
Nevin
Murray, MD, FRCPC
British
Columbia
Cancer
Agency
Vancouver,
British Columbia, Canada
Roman
Perez-Soler, MD
Montefiore
Medical Center
Bronx,
New York
Charles
M. Rudin, MD, PhD
The
Sidney Kimmel Comprehensive Cancer Center at John
Hopkins
Baltimore,
Maryland
Eric
Vallières, MD, FRCSC
Swedish
Cancer Center
Seattle,
Washington
|
|
|
|
S C I E N T I F I C A G E N D A |
|
|
| Friday, November 16, 2007
Session I: Welcome and introductory lectures
8:00 am
Welcome
8:05 am
Genetic epidemiology of lung cancer: Can we define a high-risk group?
8:30 am
Efficacies of available behavioral therapies and pharmacotherapies for smoking cessation
8:55 am
Novel targets and agents for chemoprevention
9:20 am
Panel discussion
9:40 am Coffee break
Session II: Non-small cell lung cancer (NSCLC)
10:00 am
Increasing sensitivity and specificity by combining invasive strategies with imaging tools
10:20 am
Selecting patients for adjuvant chemotherapy: What is state-of-the-art?
10:40 am
Molecular prediction of outcome and benefit in the adjuvant setting
11:00 am
Adjuvant radiotherapy for NSCLC
11:20 am
Panel discussion
11:40 am
Lunch break
Session III: Locally advanced NSCLC
12:40 pm
Potentially resectable locally advanced NSCLC: Is there a role for surgery?
1:00 pm
Contemporary strategies for optimizing chemotherapy and radiotherapy in patients with unresectable NSCLC
1:20 pm
Emerging role of targeted agents in the locally advanced setting
1:40 pm
The role of radiofrequency ablation in the treatment of lung cancer patients
2:00 pm
Panel discussion
2:20 pm
Coffee break
Session IV: Advanced NSCLC
2:40 pm
First-line treatment for advanced NSCLC
3:00 pm
Is there a role for combination regimens for second-line therapy for NSCLC?
3:20 pm
Customizing chemotherapy and targeted agents for advanced NSCLC with molecular markers
3:40 pm
Management of the elderly patient and PS2
4:20 pm
Panel discussion
4:40 pm
Adjourn
Saturday, November 17, 2007
8:00 am
Welcome to day two
Session V: Small cell lung cancer (SCLC)
8:05 am
Limited disease: Is there a state-of-the-art?
8:30 am
Targeted agents for SCLC
8:55 am
Panel discussion
9:10 am
Coffee break
Session VI: Targeted therapies and immunomodulation
9:30 am
How do we assess targeted agents with chemotherapy: Together, sequentially or separately?
9:50 am
Beyond bevacizumab: Future role of angiogenesis inhibition in NSCLC
10:10 am
Beyond angiogenesis inhibitors: Evolving role of the other targeted agents
10:30 am
TLR9 agonists and other immunomodulatory strategies
10:50 am
Update on vaccines
11:10 am
Panel discussion
11:35 am
Lunch break
Session VII: Surgical controversies in thoracic oncology
12:35 pm
Video-assisted thoracic surgical lobectomy
12:55 pm
The role of subanatomic resection for NSCLC
1:15 pm
Mediastinal neglect: Why is mediastinal assessment important and how do we contend with patients who have been inadequately staged?
1:35 pm
Panel discussion
1:55 pm
Coffee break
Session VIII: Special topics in thoracic oncology
2:15 pm
Mesothelioma: How a resistant disease became treatable
2:40 pm
Thyoma
3:05 pm
Esophageal cancer
3:30 pm
Panel discussion
3:45 pm
Chairman summary and take-home points
4:00 pm
Adjourn |
|
|
|
C O N T I N U I N G M E D I C A L
E D U C A T I O N |
|
|
|
Imedex Accreditation Services, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex Accreditation Services, LLC designates this educational activity for a maximum 13.5 of AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
|
|
|
W H O S H O U L D A T T E N
D ? |
|
|
|
This educational program is intended for oncologists, radiation therapists, thoracic surgeons, pulmonologists and other physicians in active clinical practice interested and/or involved in the management of patients with thoracic cancer. No specialized knowledge or skills other than a general familiarity with cancer and its treatment is required for successful participation in this program.
|
|
|
|
O B J E C T I V E S |
|
|
| After successfully completing this continuing medical education program participants should be able to:
- Describe the pathogenesis of lung cancer and concepts
in prevention
- Discuss and evaluate the available methods for staging of lung cancer
- Recommend the most appropriate management strategies for non-small cell lung cancer (NSCLC), including selecting patients for therapy and predicting benefit
- Recommend the most appropriate management strategies for small cell lung cancer
- Identify controversies in management of locally
advanced NSCLC
- Translate the results of recent clinical trials in lung cancer and incorporate them into clinical practice
- Outline management strategies for esophageal cancer
- Outline management strategies for mesothelioma
- Outline management strategies for thyoma
- Describe promising new targeted and immunomodulatory agents for the treatment of thoracic malignancies
- Discuss surgical issues and controversies related to treatment of thoracic cancers
|
|
|
|
|
R E G I S T R A T I O N |
|
|
| Click
here to register for this program
REGISTRATION
FEES
Discounted . . . . . . . . . . . . . . . . . . . . . . $225
Payment received by September 17, 2007
Regular . . . . . . . . . . . . . . . . . . . . . . . . .$325
Payment received by November 8, 2007
Full/Onsite: . . . . . . . . . . . . . . . . . . . . . . $425
Payment received after November 8, 2007
Group discount (physicians only). . . . . . . .–$50
Cannot be combined with any other discounts
Nurses/Residents/Students . . . . . . . . . . . .$99
proof of eligibility must accompany registration
To Register: You may register online by November 8, 2007 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting.
To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Group Discounts: Each one of multiple registrants from the same institute or practice each receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per physician. Discounts are not available for Nurses/Residents/Students rate.
Payment: To pre-register, registration and payment must be received no later than November 8, 2007. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add $25 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the conference: US Lung 291. An attendee is not registered until full payment is received.
Wire to: Bank of America, ABA: 0260.0959.3, Account Info: Imedex, Inc., Account: 0000.0106.3308. If the wire originates outside the United States, please add this additional information: Clearing Bank: Bank of America, New York, Swift Code: BOFAUS3N, Clearing Account: 6550305831.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than November 8, 2007. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after November 8, 2007.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event program content is subject to change without notice.
|
|
|
|
G E N E R A L I N F O R M A T I O N |
|
|
| Conference Location and Registration
The Westin New York at Times Square
270 West 43rd Street
New York, New York
Tel.: +1 (212) 201 2700
Fax: +1 (212) 201 2701
www.westin.com/timessquare
The Registration and Information Desk will be staffed:
Friday, November 16, 2007 7:00 am – 5:00 pm
Saturday, November 17, 2007 7:30 am – 4:00 pm
Discounted Airfares
Contact conference travel agent, Age of Travel, for assistance with your travel needs. Age of Travel can also accommodate pre- and post-conference extensions.
Tel.: +1 (800) 523 4954 or
+1 (404) 591 7120
Email: imedex@ageoftravel.com
|
|
|
|
H O T E L A C
C O M M O D A T I O N S |
|
|
|
The Westin New York at Times Square
270 West 43rd Street
New York, New York
Tel.: +1 (212) 201 2700
Fax: +1 (212) 201 2701
www.westin.com/timessquare
The Westin New York at Times Square is located at 43rd Street and 8th Avenue, in the heart of the Broadway District, with 40 theatres within walking distance. It is surrounded by the New York fashion, financial and commercial districts with easy access to the city’s subway system and within blocks of Penn Station and Grand Central Station. It is close to spectacular sights, city landmarks and incredible shopping.
For the convenience of attendees, a limited number of rooms have been reserved until October 25, 2007 at a discounted rate of $389 single/double occupancy, plus tax. This rate is not guaranteed outside the conference dates or after October 25, 2007.
To reserve your room please contact The Westin New York at Times Square reservations department at 1 (888) 627 7149 or +1 (212) 201 2700 or visit the hotel’s website at http://www.starwoodmeeting.com/Book/imedex12.
To receive the group rate, callers must identify themselves as being with the Thoracic Oncology group. Reservation requests received after October 25, 2007 may not be guaranteed the group rate. |
|
|
|
O R G A N I Z E R |
|
|
|
| ©
2007 Imedex Accreditation Services, LLC. |
|
